Syndax Pharmaceuticals, Inc. (SNDX)
17.63
+0.67
(+3.95%)
USD |
NASDAQ |
Jun 09, 15:40
Syndax Pharmaceuticals EPS Diluted (Quarterly) : -0.4835 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Celldex Therapeutics, Inc. | -1.182 |
| Viridian Therapeutics, Inc. | -1.026 |
| Ardelyx, Inc. | -0.153 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.67M |
| Revenue (Quarterly) | 64.86M |
| Total Expenses (Quarterly) | 107.54M |
| Enterprise Value | 1.495B |
| Gross Profit Margin (Quarterly) | 95.93% |
| Profit Margin (Quarterly) | -65.79% |
| Earnings Yield | -15.85% |
| Normalized Earnings Yield | -15.85 |